Targeting EGFR-overexpressed A431 cells with EGF-labeled silica-coated magnetic nanoparticles

Journal of Nanoparticle Research

Volumn 15, Issue 5, 2013, Pages

  Kralj, Slavko ^a   Rojnik, Matija ^b   Kos, Janko ^a,b   Makovec, Darko ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Bioconjugation; Cellular targeting; Colloidal stability; Functionalization; Magnetic nanoparticles

Indexed keywords

BINDING ENERGY; BIOMOLECULES; CYTOLOGY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; LANTHANUM COMPOUNDS; LIGHT SCATTERING; SILICA; SUSPENSIONS (FLUIDS);

BIO-CONJUGATION; CARBOXYL-FUNCTIONALIZED; CELLULAR TARGETING; COLLOIDAL STABILITY; EPIDERMAL GROWTH FACTORS; FUNCTIONALIZATIONS; HUMAN EPIDERMAL GROWTH FACTOR; ZETA POTENTIAL MEASUREMENTS;

MAGNETIC NANOPARTICLES;

CROSS LINKING REAGENT; CYANAMIDE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FERRIC OXIDE; NANOCOATING; SILICON DIOXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CHEMICAL INTERACTION; CONTROLLED STUDY; COVALENT BOND; DRUG CONJUGATION; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE TARGETING; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGHT SCATTERING; NANOCHEMISTRY; PRIORITY JOURNAL; STATIC ELECTRICITY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84876455927     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-1666-6     Document Type: Article

References (35)

1. Artemov D, Mori N, Ravi R, Bhujwalla ZM (2003) Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res 63:2723-2727. doi: 10.1002/mrm.10406
2. Bachran D, Schneider S, Bachran C, Urban R, Weng A, Melzig MF, Hoffmann C, Kaufmann AM, Fuchs H (2010) Epidermal growth factor receptor expression affects the efficacy of the combined application of saponin and a targeted toxin on human cervical carcinoma cells. Int J Cancer 127:1453-1461. doi: 10.1002/ijc.25123
3. Banarjee SS, Chen D-H (2009) Cyclodextrin-conjugated nanocarrier for magnetically guided delivery of hydrophobic drugs. J Nanopart Res 11:2071-2078. doi: 10.1007/s11051-008-9572-z
4. Byrne JD, Betancourt T, Brannon-Peppas L (2008) Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 60:1615-1626. doi: 10.1016/j.addr.2008.08.005
5. Čampelj S, Makovec D, Drofenik M (2008) Preparation and properties of water-based magnetic fluids. J Phys Condens Mater 20:204101. doi: 10.1088/0953-8984/20/20/204101
6. Chen H, Yeh J, Wang L, Khurshid H, Peng N, Wang AY, Mao H (2010) Preparation and control of the formation of single core and clustered nanoparticles for biomedical applications using a versatile amphiphilic diblock copolymer. Nano Res 3:852-862. doi: 10.1007/s12274-010-0056-y
7. Cho YS, Yoon TJ, Jang ES, Hong KS, Lee SY, Kim OR, Park C, Kim YJ, Yi GC, Chang K (2010) Cetuximab-conjugated magneto-fluorescent silica nanoparticles for in vivo colon cancer targeting and imaging. Cancer Lett 299:63-71. doi: 10.1016/j.canlet.2010.08.004
8. Creixell M, Herrera AP, Ayala V, Latorre-Esteves M, Perez-Torres M, Torres-Lugo M, Rinaldi C (2010) Preparation of epidermal growth factor (EGF) conjugated iron oxide nanoparticles and their internalization into colon cancer cells. J Magn Magn Mater 322:2244-2250. doi: 10.1016/j.jmmm.2010.02.019
9. Danhier F, Feron O, Preat V (2010) To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148:135-146. doi: 10.1016/j.jconrel.2010.08.027
10. Dutta RK, Sharma PK, Pandey AC (2010) Design and surface modification of potential luminomagnetic nanocarriers for biomedical applications. J Nanopart Res 12:1211-1219. doi: 10.1007/s11051-009-9801-0
11. Gabizon AA (2001) Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet. Clin Cancer Res 7:223-225
12. Garcia-Bennett A, Nees M, Fadeel B (2011) In search of the holy grail: folate-targeted nanoparticles for cancer therapy. Biochem Pharmacol 81:976-984. doi: 10.1016/j.bcp.2011.01.023
13. Goldoni S, Iozzo RA, Kay P, Campbell S, McQuillan A, Agnew C, Zhu JX, Keene DR, Reed CC, Iozzo RV (2007) A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity. Oncogene 26:368-381. doi: 10.1038/sj.onc.1209803
14. Jevnikar Z, Obermajer N, Bogyo M, Kos J (2008) The role of cathepsin X in the migration and invasiveness of T lymphocytes. J Cell Sci 121:2652-2661. doi: 10.1242/jcs.023721
15. Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J (2007) Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release 120:18-26. doi: 10.1016/j.jconrel.2007.03.012
16. Kralj S, Makovec D, Čampelj S, Drofenik M (2010) Producing ultra-thin silica coatings on iron-oxide nanoparticles to improve their surface reactivity. J Magn Magn Mater 322:1847-1853. doi: 10.1016/j.jmmm.2009.12.038
17. Kralj S, Drofenik M, Makovec D (2011) Controlled surface functionalization of silica-coated magnetic nanoparticles with terminal amino and carboxyl groups. J Nanopart Res 13:2829-2841. doi: 10.1007/s11051-010-0171-4
18. Kralj S, Rojnik M, Romih R, Jagodič M, Kos J, Makovec D (2012) Effect of surface charge on the cellular uptake of fluorescent magnetic nanoparticles. J Nanopart Res 14:1151-1165. doi: 10.1007/s11051-012-1151-7
19. Laskin JJ, Sandler AB (2004) Epidermal growth factor receptor: a promising target in solid tumours. Cancer Treat Rev 30:1-17. doi: 10.1016/j.ctrv.2003.10.002
20. Liao C, Sun Q, Liang B, Shen J, Shuai X (2011) Targeting EGFR-overexpressing tumor cells using cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide. Eur J Radiol 80:699-705. doi: 10.1016/j.ejrad.2010.08.005
21. Mahmoudi M, Sant S, Wang B, Laurent S, Sen T (2011) Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Delivery Rev 63:24-46. doi: 10.1016/j.addr.2010.05.006
22. Meira DD, de Almeida VH, Mororó JS, Nóbrega I, Bardella L, Silva RL, Albano RM, Ferreira CG (2009) Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells. Br J Cancer 101:782-791. doi: 10.1038/sj.bjc.6605216
23. Pankhurst QA, Connolly J, Jones SK, Dobson J (2003) Applications of magnetic nanoparticles in biomedicine. J Phys D 36:167-181. doi: 10.1088/0022-3727/36/13/201
24. Roberts CJ, Williams PM, Davies J, Dawkes AC, Sefton J, Edwards JC, Haymes AG, Bestwick C, Davies MC, Tendler SJB (1995) Real-space differentiation of IgG and IgM antibodies deposited on microtitre wells by scanning force microscopy. Langmuir 11:1822-1826. doi: 10.1021/la00005a063
25. Skaat H, Shafir G, Margel S (2011) Acceleration and inhibition of amyloid-β fibril formation by peptide-conjugated fluorescent-maghemite nanoparticles. J Nanopart Res 13:3521. doi: 10.1007/s11051-011-0276-4
26. Stanley SA, Gagner JE, Damanpour S, Yoshida M, Dordick JS, Friedman JM (2012) Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice. Science 336:604-608. doi: 10.1126/science.1216753
27. Suwa T, Ozawa S, Ueda M, Ando N, Kitajima M (1998) Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti-epidermal growth factor receptor antibody. Int J Cancer 75:626-634. doi: 10.1002/(SICI)1097-0215(19980209)75:4<626:AID-IJC22>3.0.CO;2-5
28. Taylor JM, Mitchell WM, Cohen S (1972) Epidermal growth factor. J Biol Chem 247:5928-5934
29. Tiefenauer LX, Kuhne G, Andres RY (1993) Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging. Bioconjug Chem 4:347-352. doi: 10.1021/bc00023a007
30. Vigor KL, Kyrtatos PG et al (2010) Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. Biomaterials 31:1307-1315. doi: 10.1016/j. biomaterials.2009.10.036
31. 2 nanoparticles for targeting ovarian cancer cells. Biomaterials 32:2166-2173. doi: 10.1016/j.biomaterials.2010.11.042
32. Wong HL, Wu XY, Bendayan R (2011) Nanotechnological advances for the delivery of CNS therapeutics. Adv Drug Delivery Rev 64:686-700. doi: 10.1016/j.addr.2011.10.007
33. Wu SH-Y, Tseng C-L, Lin F-H (2010) A newly developed Fe-doped calcium sulfide nanoparticles with magnetic property for cancer hyperthermia. J Nanopart Res 12:1173-1185. doi: 10.1007/s11051-009-9734-7
34. 4 nanoparticles for applications in biomedicine. J Mater Chem 17:3354-3362. doi: 10.1039/B702983G
35. Yang J, Lim E-K, Lee E-S, Suh J-S, Haam S, Huh Y-M (2010) Magnetoplex based on MnFe2O4 nanocrystals for magnetic labeling and MR imaging of human mesenchymal stem cells. J Nanopart Res 12:1275-1283. doi: 10.1007/s11051-009- 9837-1